disulfiram has been researched along with Uterine Cervical Neoplasms in 7 studies
Uterine Cervical Neoplasms: Tumors or cancer of the UTERINE CERVIX.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This approach provides a local treatment modality, which inevitably decreases dosing frequency and improves patient compliance." | 1.91 | Disulfiram 3D printed film produced via hot-melt extrusion techniques as a potential anticervical cancer candidate. ( Almotairy, A; Almutairi, M; Althobaiti, A; Alyahya, M; Ashour, EA; Bandari, S; Repka, MA, 2023) |
| "Disulfiram (DSF) has proven to be a promising anti-tumor drug in preclinical studies." | 1.91 | Disulfiram suppresses epithelial-mesenchymal transition (EMT), migration and invasion in cervical cancer through the HSP90A/NDRG1 pathway. ( Hu, F; Wang, Y; Wu, Y; Zheng, P, 2023) |
| "The cytotoxic effect of DSF/Cu against cervical cancer cell lines in vitro was mediated by apoptosis and autophagy simultaneously." | 1.72 | Anti-Cancer Effects of Disulfiram in Cervical Cancer Cell Lines Are Mediated by Both Autophagy and Apoptosis. ( Huang, S; Li, J; Li, L; Li, M; Li, Y; Sun, Z; Yan, Z; Zhai, Q; Zhang, W, 2022) |
| " These tablets were tested in accordance with the European Pharmacopeia testing of solid dosage form guidelines." | 1.42 | Disulfiram-loaded immediate and extended release vaginal tablets for the localised treatment of cervical cancer. ( Baffoe, CS; Boyd, P; McConville, C; Morris, M; Nguyen, N; Wang, W, 2015) |
| "Disulfiram has demonstrated antineoplastic action against prostate, breast and lung cancer." | 1.40 | Development of disulfiram-loaded vaginal rings for the localised treatment of cervical cancer. ( Boyd, P; Major, I; McConville, C; Wang, W, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, W | 1 |
| Zhai, Q | 1 |
| Li, M | 1 |
| Huang, S | 1 |
| Sun, Z | 1 |
| Yan, Z | 1 |
| Li, J | 1 |
| Li, L | 1 |
| Li, Y | 1 |
| Cao, HZ | 1 |
| Yang, WT | 1 |
| Zheng, PS | 1 |
| Almotairy, A | 1 |
| Alyahya, M | 1 |
| Althobaiti, A | 1 |
| Almutairi, M | 1 |
| Bandari, S | 1 |
| Ashour, EA | 1 |
| Repka, MA | 1 |
| Zheng, P | 1 |
| Wu, Y | 1 |
| Wang, Y | 1 |
| Hu, F | 1 |
| Pang, Y | 1 |
| Mao, SS | 1 |
| Yao, R | 1 |
| He, JY | 1 |
| Zhou, ZZ | 1 |
| Feng, L | 1 |
| Zhang, KT | 1 |
| Cheng, SJ | 1 |
| Sun, W | 1 |
| Boyd, P | 2 |
| Major, I | 1 |
| Wang, W | 2 |
| McConville, C | 2 |
| Baffoe, CS | 1 |
| Nguyen, N | 1 |
| Morris, M | 1 |
7 other studies available for disulfiram and Uterine Cervical Neoplasms
| Article | Year |
|---|---|
Anti-Cancer Effects of Disulfiram in Cervical Cancer Cell Lines Are Mediated by Both Autophagy and Apoptosis.
Topics: Animals; Apoptosis; Autophagy; Cell Line, Tumor; Copper; Disulfiram; Female; Head and Neck Neoplasms | 2022 |
Cytotoxic effect of disulfiram/copper on human cervical cancer cell lines and LGR5-positive cancer stem-like cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cisplatin; Copper; Disulfiram; Female; Humans; Neoplastic S | 2022 |
Disulfiram 3D printed film produced via hot-melt extrusion techniques as a potential anticervical cancer candidate.
Topics: Animals; Disulfiram; Drug Liberation; Female; Humans; Printing, Three-Dimensional; Sheep; Technology | 2023 |
Disulfiram suppresses epithelial-mesenchymal transition (EMT), migration and invasion in cervical cancer through the HSP90A/NDRG1 pathway.
Topics: Cell Cycle Proteins; Cell Line, Tumor; Disulfiram; Epithelial-Mesenchymal Transition; Female; Gene E | 2023 |
TGF-β induced epithelial-mesenchymal transition in an advanced cervical tumor model by 3D printing.
Topics: Biomarkers, Tumor; Cell Shape; Disulfiram; Epithelial-Mesenchymal Transition; Female; HeLa Cells; Hu | 2018 |
Development of disulfiram-loaded vaginal rings for the localised treatment of cervical cancer.
Topics: Antineoplastic Agents; Contraceptive Devices, Female; Disulfiram; Drug Carriers; Female; Humans; Tre | 2014 |
Disulfiram-loaded immediate and extended release vaginal tablets for the localised treatment of cervical cancer.
Topics: Antineoplastic Agents; Chemistry, Pharmaceutical; Delayed-Action Preparations; Disulfiram; Drug Deli | 2015 |